Welcome to CDC stacks | HPV type attribution in high grade cervical lesions in the United States - 62208 | Advisory Committee on Immunization Practices (ACIP)
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
HPV type attribution in high grade cervical lesions in the United States
Filetype[PDF-577.44 KB]


Details:
  • Supporting Files:
    No Additional Files
    1. Summary and future ACIP HPV Vaccine Workgroup plans
      Personal Author:
      Markowitz, Lauri E.
      Corporate Author:
      National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Division of STD Prevention.
      Conference Author:
      United States. Advisory Committee on Immunization Practices. Meeting (2014 February 26-27 : Atlanta, GA)
      Published:
      February 27, 2014
      Source:
      06-Flu-Cano.pdf
      Series:
      ACIP meeting Human Papillomavirus (HPV) Vaccines Update
      File Type:
      Filetype[PDF - 277.03 KB]
    2. 9-valent HPV (9vHPV) vaccine program key results
      Personal Author:
      Luxembourg, Alain
      Corporate Author:
      Merck Research Laboratories.
      Conference Author:
      United States. Advisory Committee on Immunization Practices. Meeting (2014 February 26-27 : Atlanta, GA)
      Published:
      February 27, 2014
      Source:
      05-HPV-Markowitz.pdf
      Series:
      ACIP meeting Human Papillomavirus (HPV) Vaccines Update
      File Type:
      Filetype[PDF - 255.99 KB]
    3. Population-based HPV genotype attribution in HPV-associated cancers, United States
      Personal Author:
      Saraiya, Mona
      Corporate Author:
      National Center for Chronic Disease Prevention and Health Promotion (U.S.). Division of Cancer Prevention and Control.
      Conference Author:
      United States. Advisory Committee on Immunization Practices. Meeting (2014 February 26-27 : Atlanta, GA)
      Published:
      February 27, 2014
      Source:
      05-Flu-Grohskopf.pdf
      Series:
      ACIP meeting Human Papillomavirus (HPV) Vaccines Update
      File Type:
      Filetype[PDF - 1006.96 KB]
    4. Human papillomavirus (HPV) vaccine session
      Personal Author:
      Bocchini, Joseph A.
      Corporate Author:
      United States. Advisory Committee on Immunization Practices. HPV Vaccines Work Group
      Conference Author:
      United States. Advisory Committee on Immunization Practices. Meeting (2014 February 26-27 : Atlanta, GA)
      Published:
      February 27, 2014
      Source:
      04-Mening-Patel.pdf
      Series:
      ACIP meeting Human Papillomavirus (HPV) Vaccines Update
      File Type:
      Filetype[PDF - 188.38 KB]
You May Also Like:
  1. Advisory Committee on Immunization Practices (ACIP) summary report : February 26-27, 2014, Atlanta, Georgia
    Corporate Author:
    United States. Advisory Committee on Immunization Practices.
    Conference Author:
    United States. Advisory Committee on Immunization Practices. Meeting (2014 February 26-27 : Atlanta, GA)
    Published:
    2010
    Series:
    ACIP meeting Minutes
    Description:
    February 26-27 2014 ACIP Meeting Minutes
    File Type:
    Filetype[PDF - 1.69 MB]
  2. Coming Soon
    Trends in Human Papillomavirus Vaccine Types 16 and 18 in Cervical Precancers, 2008–2014
    Personal Author:
    McClung, Nancy M.; Gargano, Julia W.; Bennett, Nancy M.; Niccolai, Linda M.; Abdullah, Nasreen; Griffin, Marie R.; Park, Ina U.; Cleveland, Angela A.; Querec, Troy D.; Unger, Elizabeth R.; Markowitz, Lauri E.;
    Corporate Author:
    HPV-IMPACT Working Group
    Published:
    February 21 2019
    Source:
    Cancer Epidemiol Biomarkers Prev. 28(3):602-609
    Description:
    Background: : The impact of human papillomavirus (HPV) vaccination has been observed in the United States through declining cervical precancer incidence in young women. To further evaluate vaccine impact, we described trends in HPV vaccine types 16/1...
    Public Access
    Available on:
    March 01, 2020
  3. 9-valent HPV vaccine (9vHPV) GRADE policy questions, available data, PICO
    Personal Author:
    Dunne, Eileen F.
    Conference Author:
    United States. Advisory Committee on Immunization Practices. Meeting (2014 June 25-26 : Atlanta, GA)
    Published:
    June 25, 2014
    Series:
    ACIP meeting Human Papillomavirus (HPV) Vaccines Update
    File Type:
    Filetype[PDF - 224.97 KB]
  4. Effect of Highly Active Antiretroviral Therapy (HAART) and Menopause on Risk of Progression of Cervical Dysplasia in Human Immune-Deficiency Virus- (HIV-) Infected Women
    Personal Author:
    Kim, Suk Chul; Messing, Susan; Shah, Krupa; Luque, Amneris E.;
    Published:
    Dec 18 2013
    Source:
    Infect Dis Obstet Gynecol. 2013; 2013.
    Description:
    More HIV-infected women are reaching older age and menopause, but there is limited information on cervical squamous intraepithelial lesions (SILs) on these women.|To assess the effect of HAART and menopause on SILs in HIV-infected women, we reviewed ...
    File Type:
    Filetype[PDF - 601.91 KB]
  5. Summary and future ACIP HPV Vaccine Workgroup plans
    Personal Author:
    Markowitz, Lauri E.
    Corporate Author:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Division of STD Prevention.
    Conference Author:
    United States. Advisory Committee on Immunization Practices. Meeting (2014 February 26-27 : Atlanta, GA)
    Published:
    February 27, 2014
    Source:
    06-Flu-Cano.pdf
    Series:
    ACIP meeting Human Papillomavirus (HPV) Vaccines Update
    File Type:
    Filetype[PDF - 277.03 KB]